Abintus Bio
PrivateLast Round
Series B
Aug 15, 2022
Total Funding Raised
$15.65M
Company Overview
Abintus Bio is a biotechnology company that develops in vivo genetic medicines designed to reprogram a patient's immune cells directly within the body.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
in vivo gene therapyCAR-T therapyimmune cell reprogrammingviral vectoroff-the-shelf CAR-Tgenetic medicineoncologyhematologic malignanciessolid tumorsbiotechdrug discoverynext-gen CAR-T
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abintus Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Abintus Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 15, 2022 | ||||
| Seed | Apr 22, 2021 |
Key People
Founding team and executive leadership
Abintus Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Skyviews Life Science | Series B |
| Tech Coast Angels | Series B |
| Leukemia & Lymphoma Society | Series B |
| SeedFolio | Series B |
| BioBrit | Series B |
| The Leukemia & Lymphoma Society (LLS) Therapy Acceleration Program (TAP) | Seed |
| Takeda Ventures | Seed, Series B |
Abintus Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abintus Bio's valuation, stock price, and market status.
Firmographic Details
HeadquartersSan Diego, California
Employee Range3
Year Founded2020
Last FundingAug 15, 2022